Stem cell death for cash-crunched Geron, Angiotech, but Mesoblast outlasts them
16 November 2011
Madeleine Armstrong
Please Login to read the full article.
16 November 2011
Madeleine Armstrong
Please Login to read the full article.
RELATED CONTENT
NEWS
- Amid conflict concerns, industry wants bigger slice of $3bn Calif stem cell initiative
- ACT jumps on encouraging data for stem cell vision treatment
- Panic! No, don't panic! ECJ embryonic stem cells ruling divides opinion
- US Capitol Capsule: Court rulings in gene patent, stem cell cases provide new hope for biopharma
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
